Update on InnomarClinics
InnomarClinics remain open to our patients amidst coronavirus (COVID-19) concerns.
Learn more.

Insights

Innomar Strategies

Webinar: 2020 pan-Canadian Oncology Drug Review (pCODR) Updates

Inverted color AmerisourceBergen icon
Innomar Strategies
September 2020

Manufacturers

Webinar: The Caregiver and Patient Support Programme

Inverted color AmerisourceBergen icon
Innomar Strategies
July 2020

Manufacturers

Webinar: Utilizing Real World Evidence Across the Product Life Cycle

Inverted color AmerisourceBergen icon
Innomar Strategies
June 2020

Manufacturers

Time-to-treatment initiation (TTI) in community infusion clinics - decreasing wait times for Canadian oncology patients

Inverted color AmerisourceBergen icon
Innomar Strategies
May 2020

Manufacturers

Regulatory Services: Submission Filing

Anne Tomalin
Anne Tomalin
Quality, Regulatory & Safety
May 2020

Manufacturers

Regulatory Services: Submission and Product Lifecycle Considerations

Anne Tomalin
Anne Tomalin
Quality, Regulatory & Safety
May 2020

Manufacturers

Regulatory Services: How are products approved?

Anne Tomalin
Anne Tomalin
Quality, Regulatory & Safety
May 2020

Manufacturers

Regulatory Services: Navigating Clinical Trial applications

Anne Tomalin
Anne Tomalin
Quality, Regulatory & Safety
May 2020

Manufacturers

Commercializing in Canada: Quality Assurance and GMP Services

Inverted color AmerisourceBergen icon
Innomar Strategies
April 2020

Manufacturers

Commercializing in Canada: Regulatory Publishing and Submissions

Inverted color AmerisourceBergen icon
Innomar Strategies
April 2020

Manufacturers

Webinar: Health Canada’s Regulatory and Quality approach to addressing COVID-19 challenges

Inverted color AmerisourceBergen icon
Innomar Strategies
April 2020

Manufacturers

3PL & Importation: Cost savings through Innomar's scalable supply chain solutions.

Inverted color AmerisourceBergen icon
Innomar Strategies
March 2020

Manufacturers

3PL & Importation: Quality-assured, temperature-controlled and secure GMP-compliant facility.

Inverted color AmerisourceBergen icon
Innomar Strategies
March 2020

Manufacturers

3PL & Importation: Supporting your product commercialization through Importation

Inverted color AmerisourceBergen icon
Innomar Strategies
March 2020

Manufacturers

Why Canada: Leveraging our partnerships and relationships to assist in your launch strategy.

Sandra Anderson
Sandra Anderson
Commercialization and Strategy
March 2020

Manufacturers

Why Canada: How we help Pharmaceutical Manufacturers commercialize their products in Canada.

Sandra Anderson
Sandra Anderson
Commercialization and Strategy
February 2020

Manufacturers

Why Canada: Is Canada an attractive market for global pharmaceutical manufacturers?

Sandra Anderson
Sandra Anderson
Commercialization and Strategy
January 2020

Manufacturers

InnomarLive 2019: Commercializing in Canada

Inverted color AmerisourceBergen icon
Innomar Strategies
December 2019

Manufacturers

Insight Series: The Value of Real-World Evidence in Canadian Drug Commercialization – Part 1

Inverted color AmerisourceBergen icon
Innomar Strategies
January 2019

InnomarLive Summary: Healthcare Innovation

Inverted color AmerisourceBergen icon
Innomar Strategies
December 2018

Manufacturers

Insight Series: Value of Patient Support Programs for Specialty Medications in Canada

Inverted color AmerisourceBergen icon
Innomar Strategies
May 2018

Infographic: The Route to Market Access in Canada

Inverted color AmerisourceBergen icon
Innomar Strategies
May 2018

Infographic: The Road to Commercialization in Canada

Inverted color AmerisourceBergen icon
Innomar Strategies
May 2018

Insight Series: Biosimilars in Canada

Inverted color AmerisourceBergen icon
Innomar Strategies
January 2018

Drug Reimbursement in Canada

Inverted color AmerisourceBergen icon
Innomar Strategies
September 2017

Improved Health Outcomes in Patients Receiving Health Case Management

Inverted color AmerisourceBergen icon
Innomar Strategies
April 2017

Understanding the Journey of a Person with a Rare Disease

Inverted color AmerisourceBergen icon
Innomar Strategies
February 2017

Specialty pharmacies enhance patient outcomes [Pharmacy Practice Plus]

Jason Zabransky
Jason Zabransky
Specialty Operations
January 2017

Case Study: Patient-centric Care in Rare Disease

Inverted color AmerisourceBergen icon
Innomar Strategies
July 2016

Future of Patient Support Programs in Canada

Sandra Anderson
Sandra Anderson
Commercialization and Strategy
June 2016

Case Study: Discovering New Opportunities for Growth in a Niche Market

Inverted color AmerisourceBergen icon
Innomar Strategies
April 2015

Case Study: Leveraging Physician Relationships to Co-create Patient Support

Inverted color AmerisourceBergen icon
Innomar Strategies
April 2015

Case Study: Optimizing a Patient Support Program to Improve Therapy Adherence

Inverted color AmerisourceBergen icon
Innomar Strategies
April 2015

Support Programs Designed to Assist Patients and Their Families

Sandra Anderson
Sandra Anderson
Commercialization and Strategy
March 2014

Nurse-led Health Case Management

Inverted color AmerisourceBergen icon
Innomar Strategies
InSight Industry Update Series

Big Wins in Record Time for Gaining Market Access with Phase II Data

Inverted color AmerisourceBergen icon
Innomar Strategies